We are live on ! Find out more
WVE icon

Wave Life Sciences
WVE

108 hedge funds and large institutions have $283M invested in Wave Life Sciences in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 30

8% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 24

2% less funds holding

Funds holding: 110 → 108 (-2)

8.37% less ownership

Funds ownership: 82.38% → 74% (-8.4%)

10% less capital invested

Capital invested by funds: $316M → $283M (-$33.1M)

21% less call options, than puts

Call options by funds: $1.32M | Put options by funds: $1.67M

Holders
108
Holders Change
-2
Holders Change %
-1.82%
% of All Funds
1.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
38
Reduced
30
Closed
24
Calls
$1.32M
Puts
$1.67M
Net Calls
-$353K
Net Calls Change
-$1.64M

Top Buyers

1
NCM
Nantahala Capital Management
Connecticut
+$8.22M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$6.65M
3
Primecap Management
Primecap Management
California
+$5.23M
4
BlackRock
BlackRock
New York
+$4.79M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.89M

Top Sellers

1
LM
Luminus Management
Texas
-$7.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$6.53M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$6.48M
4
Citadel Advisors
Citadel Advisors
Florida
-$5.13M
5
PCM
Pinz Capital Management
New York
-$4.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$61.2M – – –
Primecap Management
2
Primecap Management
California
$30.9M +$5.23M +623,080 +19%
NCM
3
Nantahala Capital Management
Connecticut
$26.4M +$8.22M +978,879 +41%
BlackRock
4
BlackRock
New York
$23.8M +$4.79M +570,466 +23%
BG
5
Bellevue Group
Switzerland
$20.5M – – –
PA
6
Perceptive Advisors
New York
$19.7M – – –
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$11.8M +$6.65M +792,844 +112%
Morgan Stanley
8
Morgan Stanley
New York
$9.81M +$1.04M +124,153 +11%
JP Morgan Chase
9
JP Morgan Chase
New York
$8.59M -$319K -37,987 -3%
Vanguard Group
10
Vanguard Group
Pennsylvania
$6.43M +$2.89M +344,475 +73%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$6.03M -$1.96M -233,522 -23%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$4.95M +$2.61M +310,515 +97%
State Street
13
State Street
Massachusetts
$4.27M +$662K +78,841 +17%
Jacobs Levy Equity Management
14
Jacobs Levy Equity Management
New Jersey
$3.6M +$40.2K +4,788 +1%
SFM
15
Sphera Funds Management
Israel
$3.27M -$4.33M -516,241 -55%
Northern Trust
16
Northern Trust
Illinois
$3.18M +$763K +90,898 +29%
Alyeska Investment Group
17
Alyeska Investment Group
Illinois
$2.34M -$6.48M -771,816 -72%
ACM
18
Asymmetry Capital Management
California
$2.21M +$2.36M +280,924 New
Renaissance Technologies
19
Renaissance Technologies
New York
$1.85M +$1.98M +235,620 New
Fidelity Investments
20
Fidelity Investments
Massachusetts
$1.77M -$479K -57,100 -20%
Charles Schwab
21
Charles Schwab
California
$1.77M +$657K +78,246 +54%
Barclays
22
Barclays
United Kingdom
$1.77M +$985K +117,416 +110%
PIM
23
Platinum Investment Management
Australia
$1.62M – – –
GTC
24
Ghost Tree Capital
New York
$1.57M -$1.89M -225,000 -53%
PAMU
25
Pictet Asset Management (UK)
United Kingdom
$1.3M – – –
1
2 3 4 5

WVE Hedge Fund Activity: Q4 2020 in Review

108 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q4 2020, worth a combined $283M — down 10% from $316M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of WVE and 22 opened new positions — a net loss of 2 holders — while 30 trimmed existing stakes and 38 added.

The largest buyer was Nantahala Capital Management, adding an estimated $8.22M. The largest seller was Luminus Management, exiting entirely with an estimated $7.6M sold.

  • 108 institutional investors held Wave Life Sciences (WVE) as of Q4 2020, down from 110 in Q3 2020.
  • Funds reported $283M of Wave Life Sciences stock for Q4 2020, down 10% quarter-over-quarter.
  • 22 funds opened new Wave Life Sciences positions in Q4 2020 and 24 closed out, a net change of -2 holders.
  • The largest Wave Life Sciences buyer in Q4 2020 was Nantahala Capital Management, an estimated $8.22M added.
  • The largest Wave Life Sciences seller in Q4 2020 was Luminus Management, an estimated $7.6M sold.

Based on aggregated 13F filings for Q4 2020.